Discover 1,072 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,072
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
for
Obesity, Overweight, Osteoarthritis, Knee
Location: Levis, Sherbrooke, Waterbury CT, Quebec, New York NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07509307
Phase3, Recruiting
Active & Responsive
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: East Stroudsburg PA, Wilmington DE, Bethlehem PA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07091617
Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Boston MA, Worcester MA, New York NY, Exton PA,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase3, Recruiting
Active & Responsive
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
for
Chronic Low Back Pain
Location: Boston MA, Orlando FL, Asheville NC, Decatur GA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04142177
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: Burlington VT, Hershey PA, Charlottesville VA,
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase1, Phase2, Recruiting
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT04038502
Phase2, Recruiting
Active & Responsive
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
for
Myasthenia Gravis
Location: Lake Success NY, Philadelphia PA, Durham NC,
Sponsor: Ad scientiam
Sex: All
Age: 18+
Code: NCT05564936
Recruiting
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Columbia MD, Fairfax VA, Margate FL, Plantation FL,
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase2, Recruiting
Active & Responsive
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
for
Keratoconus, Unstable, Bacterial Keratitis, Ectasia of Cornea
Location: Eugene OR
Sponsor: Pacific Clear Vision Institute
Sex: All
Age: 12 - 45
Code: NCT03918408
Phase1, Recruiting
Active & Responsive
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
for
Mycobacterium Avium Complex Pulmonary Disease
Location: Calgary, Portland OR
Sponsor: Radboud University Medical Center
Sex: All
Age: 18+
Code: NCT05906316
Recruiting
Active & Responsive
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT05943496
Phase1, Recruiting
Active & Responsive
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
for
Yellow Fever, Immunization; Infection
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 20 - 49
Code: NCT05859490
Phase1, Phase2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Norfolk VA, Nashville TN, Skokie IL, Houston TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Halifax, Boston MA, New Haven CT, Queens NY,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
for
Polycythemia Vera
Location: New York NY, Bethesda MD, Chapel Hill NC, Cleveland OH,
Sponsor: Italfarmaco
Sex: All
Age: 18+
Code: NCT06093672
Phase3, Recruiting
Active & Responsive
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
for
Immune Surveillance
Location: Klamath Falls OR
Sponsor: Natural Immune Systems Inc
Sex: All
Age: 18 - 70+
Code: NCT05364710
Recruiting
Active & Responsive
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
for
Morton Neuroma
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 70+
Code: NCT05501262
Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,